A secondary analysis of the STEP TEENS trial, presented at the European Congress on Obesity (ECO 2023) and published in Obesity, demonstrates the significant effects of semaglutide on adolescent weight loss. Led by Dr. Aaron S. Kelly from the University of Minnesota, the study reveals that 45% of the adolescents who received se...